Showing 1 - 5 results of 5 for search 'Shereen Elazzazy', query time: 0.03s
Refine Results
-
1
-
2
The effectiveness and safety of palbociclib and ribociclib in stage IV HR+/HER-2 negative breast cancer: a nationwide real world comparative retrospective cohort study by Nour Hisham Al-Ziftawi, Shereen Elazzazy, Mohammed Fasihul Alam, Asrul Shafie, Anas Hamad, Anas Hamad, Salha Bbujassoum, Mohamed Izham Mohamed Ibrahim
Published 2023-12-01
Article -
3
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review by Nabil E. Omar, Kareem A. El-Fass, Abdelrahman I. Abushouk, Noha Elbaghdady, Abd Elmonem M. Barakat, Ahmed E. Noreldin, Dina Johar, Mohamed Yassin, Anas Hamad, Shereen Elazzazy, Said Dermime
Published 2020-10-01
Article -
4
Post‐COVID‐19‐associated multiorgan complications or “long COVID” with literature review and management strategy discussion: A meta‐analysis by Phool Iqbal, Fateen Ata, Hassan Chaudhry, Bassam Muthanna, Hafiz Waqas Younas, Syed Ata ul Munamm, Rohit Sharma, Kahtan Fadah, Shereen Elazzazy, Anas Hamad, Osama Said Abu Tabar, Nabil E. Omar
Published 2023-04-01
Article -
5
Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP) by Anas Hamad, Shereen Elazzazy, Salha Bujassoum, Kakil Rasul, Javid Gaziev, Honar Cherif, Zakiya Al-Boloshi, Yolande Hanssens, Ayman Saleh, Hadi Abu Rasheed, Daoud Al-Badriyeh, Ahmed Babiker, Amid Abu Hmaidan, Moza Al-Hail
Published 2023-01-01
Article